M&A Deal Summary

LifeMD Acquires Cleared

On January 12, 2022, LifeMD acquired healthcare services company Cleared

Acquisition Highlights
  • This is LifeMD’s 1st transaction in the Healthcare Services sector.
  • This is LifeMD’s 1st transaction in the United States.
  • This is LifeMD’s 1st transaction in New York.

M&A Deal Summary

Date 2022-01-12
Target Cleared
Sector Healthcare Services
Buyer(s) LifeMD
Deal Type Add-on Acquisition

Target

Cleared

New York, New York, United States
Cleared is a telehealth brand that provides personalized treatments for allergy, asthma, and immunology. Its offerings include in-home tests for both environmental and food allergies, prescriptions for allergies and asthma, and FDA-approved immunotherapies for treating chronic allergies. It boasts a network of medical professionals and providers in all 50 states, a growing pipeline of pharmaceutical partners, and treatments and tests that cost up to 50 percent less than the brand-name competition. The offerings include free consultations and ongoing care from U.S.-licensed allergists and nurses. Clearedis based in New York.

Search 214,557 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

LifeMD

New York, New York, United States

Category Company
Founded 1994
Sector Information Technology
Employees304
Revenue 152M USD (2023)
DESCRIPTION

LifeMD is a rapidly growing direct-to-patient telehealth company that offers cash-pay virtual medical care across all 50 states. LifeMD’s telemedicine platform enables virtual access to affordable and convenient medical treatment from licensed providers and, when appropriate, prescription medications and over-the-counter products delivered directly to the patient's home. LifeMD was founded in 1994 and is based in New York, New York.


DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New York M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1